Latest News about CPRX
Recent news which mentions CPRX
7 Penny Stock Companies That Actually Make Money
February 19, 2021
From InvestorPlace
Looking Into Catalyst Pharmaceuticals's Return On Capital Employed
January 28, 2021
Tickers
CPRX
From Benzinga
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
January 27, 2021
From Benzinga
3 Top Small-Cap Stocks to Buy in January
January 09, 2021
From Motley Fool
The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks
December 26, 2020
From Benzinga
A Look Into Healthcare Sector Value Stocks
December 14, 2020
From Benzinga
5 Value Stocks In The Healthcare Sector
November 02, 2020
From Benzinga
Looking Into Catalyst Pharmaceuticals's Return On Capital Employed
October 28, 2020
Tickers
CPRX
From Benzinga
Return On Capital Employed Overview: Catalyst Pharmaceuticals
October 06, 2020
Tickers
CPRX
From Benzinga
The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVac
September 30, 2020
From Benzinga
Why Catalyst Pharmaceuticals Stock Crashed in August
September 08, 2020
Tickers
CPRX
From Motley Fool
3 Awful Stocks Robinhood Investors Love -- and 1 of the Best
August 19, 2020
From Motley Fool
Robinhood Investors Love These 3 Biotech Stocks. Should You?
August 18, 2020
From Motley Fool
3 Stocks Robinhood Investors Love
August 16, 2020
From Motley Fool
77 Biggest Movers From Yesterday
August 12, 2020
From Benzinga
Tickers
CPRX
From Motley Fool
58 Stocks Moving In Tuesday's Mid-Day Session
August 11, 2020
From Benzinga
From Benzinga
38 Stocks Moving in Tuesday's Pre-Market Session
August 11, 2020
From Benzinga
15 Stocks Moving In Monday's After-Hours Session
August 10, 2020
From Benzinga
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
August 09, 2020
From Benzinga
3 Biotech Stocks Robinhood Investors Love, and 1 They Should
August 08, 2020
From Motley Fool
Here's How Much Investing $1,000 In Catalyst Pharmaceuticals In 2010 Would Be Worth Today
August 04, 2020
Tickers
CPRX
From Benzinga
From Motley Fool
The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions
June 18, 2020
From Benzinga
Tickers
CPRX
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.